ArticleMedical & biological engineering & computing2025
An intelligent magnetic resonance imagining-based multistage Alzheimer's disease classification using swish-convolutional neural networks.
Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An integrated deep learning model for early and multi-class diagnosis of Alzheimer's disease from MRI scans.Scientific reports · 2025Article
- Developments in Deep Learning Artificial Neural Network Techniques for Medical Image Analysis and Interpretation.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) refers to a neurological disorder that causes damage to brain cells and results in decreasing cognitive abilities and memory. In brain scans, this degeneration can be seen in different ways. The disease can be classified into four stages: Non-demented (ND), moderate demented (MoD), mild demented (MiD), and very mild demented (VMD). To prepare the raw dataset for analysis, the collected magnetic resonance imaging (MRI) images are subjected to several pre-processing techniques in order to improve the performance accuracy of the proposed model. Medical images generally have poor contrast and get affected by noise, which ends up with inaccurate diagnosis. For the different phases of AD to be detected, a clear image is necessary. To address this issue, the influence of the artefacts must be reduced, enhance the contrast, and reduce the loss of information. A novel framework for image enhancement is suggested to increase the accuracy in the detection and identification of AD. In this study, the raw MRI dataset from the Alzheimer's disease neuroimaging initiative (ADNI) database is subjected to skull stripping, contrast enhancement, and image filtering followed by data augmentation to balance the dataset with four types of Alzheimer's classes. The pre-processed data are subjected to five different pre-trained models such as AlexNet, ResNet, VGG 16, EfficientNet, and Inceptionv3 achieving a testing accuracy rate of 91.2%, 88.21%, 92.34%, 93.45%, and 85.12%, respectively. These pre-trained models are compared with the proposed CNN (convolutional neural network) model designed with Adam optimizer and Flatten Swish activation function which reaches the highest accuracy of 96.5% with a learning rate of 0.000001. The five pre-trained CNN models along with the proposed swish-based AD-CNN were tested using various performance metrics to evaluate the model efficiency in classifying and identifying the AD classes. From the result analysis, it is evident that the proposed AD-CNN model outperforms all the other models.
Indexed as
Identifiers
39546213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.